Company Filing History:
1 out of 832,812 Years Active: 2011
Title: Hirofumi Hamada: Innovator in Therapeutic Agents for Cranial Nerve Diseases
Introduction
Hirofumi Hamada is a notable inventor based in Hokkaido, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of cranial nerve diseases. His innovative approach involves the use of mesenchymal cells as active ingredients in therapeutic agents.
Latest Patents
Hamada holds a patent for "Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient." This patent highlights the effectiveness of intravenous administration of bone marrow cells collected from rat bone marrow or peripheral blood in treating cerebral infarction. The research indicates that both human and murine bone marrow stem cells exhibit similar therapeutic effects. Mesenchymal cells, including bone marrow cells, cord blood cells, or peripheral blood cells, can be utilized as agents for in vivo administration against cranial nerve diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Hirofumi Hamada has focused on advancing medical treatments through innovative research. His work has contributed to a better understanding of how mesenchymal cells can be harnessed for therapeutic purposes.
Collaborations
Hamada has collaborated with Osamu Honmou, further enhancing the research and development of therapeutic agents in their field.
Conclusion
Hirofumi Hamada's contributions to the medical field through his innovative patent demonstrate the potential of mesenchymal cells in treating cranial nerve diseases. His work continues to inspire advancements in therapeutic research.